The purpose of this study is to investigate long-term treatment with Zomacton® for pituitary short stature in children with insufficient growth hormone production and/or short stature caused by Turner syndrome.
Study Type
OBSERVATIONAL
Enrollment
1,034
Drug given by prescription
Efficacy of ZOMACTON
measured by: body height, increase of body height per annum
Time frame: Up to 5 years
Efficacy measured by further parameters
measured by: weight, increase weight per annum sitting height, increase of sitting height per annum head circumference per annum bone age, increase of bone age per annum puberty development IGF-1, IGFBP-3 psychological cofactors
Time frame: Up to 5 years
Safety of Zomacton and application device
measured by: local adverse reactions to the application device adverse events of Zomacton safety laboratory
Time frame: Up to 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Investigational Site
Konrad-Adenauer-Allee 33, Augsburg, Germany
Investigational Site
Friedrichstr. 36-42, Dresden, Germany
Investigational Site
Blücherstr. 4, Erfurt, Germany
Investigational Site
Loschgestr. 15, Erlangen, Germany
Investigational Site
Düsseldorfer Str. 1-7, Frankfurt (Main), Germany
Investigational Site
Stresemannallee 1-3, Frankfurt (Main), Germany
Investigational Site
Wilhelm-Breckow-Allee 20, Gummersbach, Germany
Investigational Site
Seminarstr. 2, Heidelberg, Germany
Investigational Site
Koblenzer Str. 115-155, Koblenz, Germany
Investigational Site
Elisenstr. 12, Oldenburg, Germany
...and 49 more locations